The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity

1. Ibanez, E.
2. Agliano, A.
3. Prior, C.
4. Nguewa, P.
5. Redrado, M.
6. Gonzalez-Zubeldia, I.
7. Plano, D.
8. Palop, J.A.
9. Sanmartin, C.
10. Calvo, A.